Golden Ticket Competition

 

Applications open

Sanofi is now accepting submissions for the 2022 Sanofi Golden Ticket Competition!

Sanofi is a global sponsor of BioLabs, a premier shared laboratory space for life science and biotech startups to test new ideas and innovate. …

2 Min
More

Combination is key – new treatments for lung and colon cancer?

Researchers from the Experimental Pharmacology and Oncology (EPO) in Berlin-Buch in cooperation with academic partners identified new experimental approaches to treat therapy resistant cancer.

Patients with advanced colon cancer have limited…

3 Min
More

Interview with Jasper Emeis, research associate of the GrOwnValve project

GrownValve is a spin-off of the Deutsches Herzzentrum Berlin and Charité. The company was founded in 2019. It develops patient-specific, endogenous heart valves, with a focus on pediatrics. We interview Jasper Emeis, research associate of GrOwnValve…

3 Min
More

​​​​​​​Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176

 

Berlin, 10 January 2022. Eckert & Ziegler Radiopharma GmbH (EZR), the radiopharmaceutical production arm of Eckert & Ziegler, has signed a joint venture and exclusive long-term supply agreements for Ytterbium-176 with Atom Mines LLC, an innovative…

2 Min
More

Imvaq Therapeutics signs a Service and Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

 

Berlin, Germany and New York, USA, January 6, 2022:

ProBioGen AG is delighted to announce the execution of a service and commercial product license agreement with Imvaq Therapeutics, a biotech company developing innovative cancer immunotherapies.…

2 Min
More

BBI Solutions completes Acquisition of BioTeZ Berlin-Buch GmbH

 

BBI Solutions, the world’s leading independent provider of immuno-diagnostic reagents and contract services, has today announced the acquisition of “Biotez”.

BioTeZ Berlin-Buch GmbH (also including Steffens Biotechnische Analysen GmbH), is a…

2 Min
More

Astellas and Pantherna Enter into Technology Evaluation Agreement for Research of mRNA-based Regenerative Medicine

TOKYO and Hennigsdorf, Germany, November 15, 2021 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pantherna Therapeutics GmbH (CEO: Klaus Giese, Ph.D., “Pantherna”) today announced that the companies have…

3 Min
More

Eckert & Ziegler Acquires Property for Radiopharmaceutical Production Site in China

 

Berlin, 5 November 2021. Eckert & Ziegler AG (ISIN DE0005659700), a global specialist for isotope applications in medicine and industry has acquired an approximately 7,000 m² property with an expansion option for the building of its Chinese…

2 Min
More

New Berlin Cell Hospital announced

When cells make the wrong decision, diseases ensue. This insight came from Berlin – namely from Rudolf Virchow, whose 200th birthday is being celebrated this year. To mark the anniversary, Berlin research institutions have announced the founding of…

4 Min
More
Show more items